Profil
Christopher Nishan Garabedian is the founder and currently holds the position of Chairman & Chief Executive Officer at Xontogeny LLC, which was founded in 2016.
He is also currently serving as Chairman at Bioharmony Therapeutics, Inc., Forge Biologics, Inc., Massachusetts Biotechnology Council, AsclepiX.
Therapeutics LLC, Zucara Therapeutics, Inc., VivoSense, Inc, Polycore Therapeutics, Inc., and Forge Biologics Holdings LLC.
Additionally, he is a Director at Massachusetts Biotechnology Council, AsclepiX.
Therapeutics LLC, Zucara Therapeutics, Inc., VivoSense, Inc, Polycore Therapeutics, Inc., and Forge Biologics Holdings LLC.
Mr. Garabedian is also a Portfolio Manager at Perceptive Advisors (Private Equity) since 2017.
Previously, he held the positions of President, Chief Executive Officer & Director at Sarepta Therapeutics, Inc. from 2012 to 2015, and Chairman at Landos Biopharma, Inc. from 2021 to 2024.
He has also served as a Director at Vyome Therapeutics, Inc. and Vice President-Corporate Strategy at Celgene Corp.
Mr. Garabedian completed his undergraduate degree at the University of Maryland.
Postes actifs de Christopher Garabedian
| Sociétés | Poste | Début |
|---|---|---|
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Directeur Général | 01/06/2016 |
Bioharmony Therapeutics, Inc.
Bioharmony Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Président | - |
Forge Biologics, Inc.
Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company | Président | - |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Directeur/Membre du Conseil | - |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Directeur/Membre du Conseil | - |
Forge Biologics Holdings LLC
Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | - |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Directeur/Membre du Conseil | - |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Membre du Conseil | - |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Private Equity Investor | 01/05/2017 |
| ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Christopher Garabedian
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Formation de Christopher Garabedian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company that develops medicines to treat immuno-inflammatory diseases | Health Technology |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Commercial Services |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Landos Biopharma, Inc.
Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Health Technology |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Health Technology |
VivoSense, Inc
VivoSense, Inc Data Processing ServicesTechnology Services Operates as a data analysis consulting and software company | Technology Services |
Bioharmony Therapeutics, Inc.
Bioharmony Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Health Technology |
Forge Biologics, Inc.
Forge Biologics, Inc. BiotechnologyHealth Technology Operates as a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company | Health Technology |
Forge Biologics Holdings LLC
Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
















